Springer Nature is making SARS-CoV-2 and COVID-19 research free View research | View latest news | Sign up for updates

The use of fibric acid derivatives combined with rosiglitazone appears to decrease HDL cholesterol levels in patients with diabetes mellitus (DM)

    • 8 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Keidar S, Guttmann H, Stam T, Fishman I, Shapira C.High incidence of reduced plasma HDL cholesterol in diabetic patients treated with rosiglitazone and fibrate. Pharmacoepidemiology and Drug Safety 16: 1192-1194, No. 11, Nov 2007

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    The use of fibric acid derivatives combined with rosiglitazone appears to decrease HDL cholesterol levels in patients with diabetes mellitus (DM). React. Wkly. 1184, 5 (2008). https://doi.org/10.2165/00128415-200811840-00017

    Download citation

    Keywords

    • Public Health
    • Lipid
    • Cholesterol
    • Diabetes Mellitus
    • Cholesterol Level